Chemed Corp: Form 10-Q for the period ended Jun 30, 2010
Filed with the SEC on Jul 30, 2010 and accepted by EDGAR at Jul 30, 2010, 15:48 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2010-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2010-04-01 to 2010-06-30 | $315.0m | us-gaap:SalesRevenueNet |
| Revenue | 6 months2010-01-01 to 2010-06-30 | $623.8m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2010-04-01 to 2010-06-30 | $223.7m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2010-01-01 to 2010-06-30 | $442.8m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2010-04-01 to 2010-06-30 | $50.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2010-01-01 to 2010-06-30 | $98.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2010-04-01 to 2010-06-30 | $33.9m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2010-01-01 to 2010-06-30 | $68.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2010-04-01 to 2010-06-30 | $3.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2010-01-01 to 2010-06-30 | $6.0m | us-gaap:InterestExpense |
| Income tax | 3 months2010-04-01 to 2010-06-30 | $12.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2010-01-01 to 2010-06-30 | $24.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2010-04-01 to 2010-06-30 | $18.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months2010-01-01 to 2010-06-30 | $38.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2010-04-01 to 2010-06-30 | $0.82 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2010-01-01 to 2010-06-30 | $1.66 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2010-04-01 to 2010-06-30 | $0.83 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2010-01-01 to 2010-06-30 | $1.69 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2010-04-01 to 2010-06-30 | 23,080,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2010-01-01 to 2010-06-30 | 23,012,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2010-01-01 to 2010-06-30 | $20.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2010-01-01 to 2010-06-30 | $11.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2010-01-01 to 2010-06-30 | $5.5m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2010-01-01 to 2010-06-30 | $10.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2010-06-30 | $109.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2010-06-30 | $244.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2010-06-30 | $866.0m | us-gaap:Assets |
| Current liabilities | At period end2010-06-30 | $141.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2010-06-30 | $353.0m | us-gaap:Liabilities |
| Long-term debt | At period end2010-06-30 | $155.6m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2010-06-30 | $513.0m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2010-06-30 | 22,787,983 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001157523-10-004512. Last ingested by Listed: Nov 14, 2026, 12:29 ET. Listed shows no prices and gives no investment advice.